Store director Diana Kelly at Specsavers Linlithgow is one of just a handful of opticians across the country who have successfully completed an SQA qualification in glaucoma management and is able to ...

Glaucoma often progresses silently, damaging vision before you even notice a problem. Experts warn that believing common ...

Nigeria’s leading eye care provider, Skipper Eye-Q Super Speciality Eye Hospital, Lagos, has called for increased glaucoma screening across the country, warning that many people remain unaware of the ...

Addison-based Premier Vision of Dallas is helping families understand childhood myopia and the importance of early ...

Artelo Biosciences (ARTL) stock jumped 40% after announcing a fully-funded glaucoma trial for ART27.13 with Belfast Health and Social Care Trust.

Artelo Biosciences (NASDAQ: ARTL) has announced its entry into the ophthalmology space with a fully funded clinical study evaluating ART27.13 in glaucoma patients. The investigator-sponsored trial ...

Investigator-sponsored study funded by Glaucoma UK and the HSC R&D Division expands ART27.13’s clinical potential into ophthalmologyFirst ...

US News evaluated freestanding ASCs only, excluding hospital-affiliated outpatient departments to avoid overlap with hospital rankings and maintain comparability across facility types. Methodology ...

SpyGlass Pharma Inc., which is promising an intraocular lens that will reshape the treatment of glaucoma, emerged from its initial public offering last month with a big boost from Wall Street.

Open-angle glaucoma is a risk factor for vascular and frontotemporal dementia in patients with type 2 diabetes, according to a study.

Glaucoma is a leading cause of irreversible blindness worldwide and often goes undiagnosed until vision loss is advanced.

AI could revolutionise glaucoma detection. Here’s 6 things everyone should know - Age and family history are significant risk ...